 LA JOLLA, Calif.--BUSINESS WIRE--DermTech, Inc. NASDAQ: DMTK DermTech, a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today the additions of Dr. Klaus Busam, Dr. Joslyn Kirby and Dr. Justin Ko to its Scientific Advisory Board the Board. The Board provides their expertise and unique perspectives, to support DermTechs existing innovations, development of new technologies as well as emerging technologies that may impact dermatological dis 